Rules-Based Medicine
Latest round
- Series A
Last raised
- Oct 2007
Total raised
- $25M
Investors
- 3
About Rules-Based Medicine
Rules-Based Medicine Inc.Rules-Based Medicine Inc. specializes in biomarker analysis and immunoassays, aiming to enhance research in therapeutic applications. Established in Austin, Texas, the company underwent a pivotal change when it was sold to Myriad Genetics in April 2011 for USD 80 mn. The total number of deals reported stands at 2.MyriadRBM focuses on advancing research and development in biomarker technology and immunoassays. Their offerings include a variety of assays and testing services that facilitate the discovery and validation of biomarkers essential for therapeutic applications. The company serves a diverse clientele consisting of pharmaceutical firms, academic institutions, and clinical research organizations, all reliant on accurate biomarker data for drug development and diagnostics. MyriadRBM’s products are primarily utilized in research areas such as oncology, neurology, and infectious disease, aimed at improving patient management and treatment strategies.MyriadRBM generates revenue through contract research services, direct sales of testing kits, and collaborations with pharmaceutical companies. The company follows a transactional structure featuring B2B arrangements where clients utilize their biomarker assays during drug development. Pricing is determined by the complexity and specificity of the assays, with flagship products commanding premium pricing due to their advanced capabilities.Looking ahead, MyriadRBM aims to introduce new products designed for enhanced biomarker analysis by 2012, further expanding their portfolio. The company plans to enter additional geographic markets, specifically targeting growth in Europe and parts of Asia by 2023.
Who invested in Rules-Based Medicine
3 investors across 1 round
See all investors in Rules-Based Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 25, 2007
Amount
$25M
Investors
Questions about Rules-Based Medicine
Who invested in Rules-Based Medicine?
Rules-Based Medicine has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rules-Based Medicine raised?
Rules-Based Medicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rules-Based Medicine last raise money?
Rules-Based Medicine's most recent round on record is a Series A, in Oct 2007.
What does Rules-Based Medicine do?
Rules-Based Medicine is a biotechnology company.
Where is Rules-Based Medicine headquartered?
Rules-Based Medicine is headquartered in Austin, US.
Which VCs invest in companies like Rules-Based Medicine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rules-Based Medicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rules-Based Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.